- Home
- ACT vs BRKR Comparison
ACT vs BRKR Comparison
Compare ACT & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACT
- BRKR
- Stock Information
- Founded
- ACT 1981
- BRKR 1960
- Country
- ACT United States
- BRKR United States
- Employees
- ACT N/A
- BRKR N/A
- Industry
- ACT Specialty Insurers
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- ACT Finance
- BRKR Industrials
- Exchange
- ACT Nasdaq
- BRKR Nasdaq
- Market Cap
- ACT 5.5B
- BRKR 5.3B
- IPO Year
- ACT 2021
- BRKR 2000
- Fundamental
- Price
- ACT $34.91
- BRKR $37.26
- Analyst Decision
- ACT Hold
- BRKR Buy
- Analyst Count
- ACT 3
- BRKR 10
- Target Price
- ACT $39.00
- BRKR $49.67
- AVG Volume (30 Days)
- ACT 306.8K
- BRKR 3.0M
- Earning Date
- ACT 11-05-2025
- BRKR 11-03-2025
- Dividend Yield
- ACT 2.37%
- BRKR 0.53%
- EPS Growth
- ACT 6.06
- BRKR N/A
- EPS
- ACT 4.41
- BRKR 0.52
- Revenue
- ACT $1,223,030,000.00
- BRKR $3,442,800,000.00
- Revenue This Year
- ACT $4.10
- BRKR $4.30
- Revenue Next Year
- ACT $3.52
- BRKR $1.51
- P/E Ratio
- ACT $7.92
- BRKR $72.47
- Revenue Growth
- ACT 3.15
- BRKR 10.36
- 52 Week Low
- ACT $30.79
- BRKR $28.53
- 52 Week High
- ACT $39.47
- BRKR $64.64
- Technical
- Relative Strength Index (RSI)
- ACT 36.38
- BRKR 53.27
- Support Level
- ACT $34.64
- BRKR $38.60
- Resistance Level
- ACT $36.94
- BRKR $41.08
- Average True Range (ATR)
- ACT 0.63
- BRKR 1.50
- MACD
- ACT -0.06
- BRKR -0.10
- Stochastic Oscillator
- ACT 11.74
- BRKR 30.80
About ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.